Welcome to our dedicated page for Greenlit Ventures SEC filings (Ticker: GLVT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Greenlit Ventures's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Greenlit Ventures's regulatory disclosures and financial reporting.
Greenlit Ventures Inc. notified the SEC that its Form 10-K for the period ended December 31, 2025 could not be filed on time because the company had difficulties finalizing audit materials that "could not be eliminated without unreasonable effort or expense." The company executed a Rule 12b-25 notification dated April 1, 2026.
Greenlit Ventures Inc. (GLVT) filed its Q3 2025 report, showing continued operating losses and liquidity strain. The company reported a net loss of $9,371 for the quarter and $38,999 for the nine months ended September 30, 2025, with no revenue. Interest expense was $3,788 in Q3 and $10,548 year-to-date.
Liquidity remains challenged: the balance sheet shows $0 cash, current liabilities of $36,943, and a working capital deficit of $36,943. Non-current convertible notes totaled $191,001, bearing 8% interest and maturing on December 31, 2027, convertible at $0.05 per share. Accumulated deficit reached $762,159. Management disclosed “substantial doubt” about the company’s ability to continue as a going concern.
Shares outstanding were 4,082,479 as of October 14, 2025. The company recorded $0 stock-based compensation year-to-date versus $175,000 in the prior-year period, contributing to the lower year-over-year loss. Management concluded disclosure controls and procedures were not effective as of the period end.